A Study of HS-10518 in Healthy Female Participants
Status:
Not yet recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and
pharmacodynamics of HS-10518 in healthy adult premenopausal females in China.